DANTROLENE SODIUM FOR INJECTION, USP
Google image searchProduct monograph
Active ingredient
dantrolene sodium, 20 MG/VIAL
DIN: 02529998
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE DOSE VIALS
Schedule: Prescription
Company: HIKMA CANADA LIMITED
Date: 29-MAR-2023
ATC:
- M03 — MUSCLE RELAXANTS (ATC, ATC/DDD, )
- M03C — MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS (ATC, ATC/DDD)
- M03CA — Dantrolene and derivatives (ATC, ATC/DDD)
- M03CA01 — DANTROLENE (ATC/DDD)
Reference brand drug: Dantrium
Pharmaceutical standard: USP
